Tag Archives: ADF

Mundipharma in deal to distribute Penthrox

Mundipharma has entered an exclusive Australian distribution agreement with Medical Developments International (MVP) for the non-opioid pain medication Penthrox (methoxyflurane). Penthrox is self-administered through a custom-built inhaler under the supervision of a treating healthcare practitioner and should bring pain relief in six to 10 breaths. It is indicated for short-term …

Read More »